1. Academic Validation
  2. Furazans in Medicinal Chemistry

Furazans in Medicinal Chemistry

  • J Med Chem. 2021 Feb 25;64(4):1786-1815. doi: 10.1021/acs.jmedchem.0c01901.
Ross S Mancini 1 Christopher J Barden 1 Donald F Weaver 2 3 4 Mark A Reed 1 2
Affiliations

Affiliations

  • 1 Treventis Corporation, Toronto, Ontario M5T 0S8, Canada.
  • 2 Department of Fundamental Neurobiology, Krembil Research Institute, Toronto, Ontario M5T 0S8, Canada.
  • 3 Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada.
  • 4 Department of Medicine, University of Toronto, Toronto, Ontario M5S 3H2, Canada.
Abstract

Incorporation of heterocycles into drug molecules can enhance physical properties and biological activity. A variety of heterocyclic groups is available to medicinal chemists, many of which have been reviewed in detail elsewhere. Oxadiazoles are a class of heterocycle containing one oxygen and two nitrogen atoms, available in three isomeric forms. While the 1,2,4- and 1,3,4-oxadiazoles have seen widespread application in medicinal chemistry, 1,2,5-oxadiazoles (furazans) are less common. This Review provides a summary of the application of furazan-containing molecules in medicinal chemistry and drug development programs from analysis of both patent and academic literature. Emphasis is placed on programs that reached clinical or preclinical stages of development. The examples provided herein describe the pharmacology and biological activity of furazan derivatives with comparative data provided where possible for Other heterocyclic groups and pharmacophores commonly used in medicinal chemistry.

Figures